Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,046,000 | 921,000 | 908,000 | 1,015,000 | 2,080,000 |
| Depreciation Amortization | 570,000 | 493,000 | 439,000 | 437,000 | 408,000 |
| Income taxes - deferred | 105,000 | 13,000 | -49,000 | 1,000 | -57,000 |
| Accounts receivable | -106,000 | -71,000 | -15,000 | 246,000 | 81,000 |
| Other Working Capital | 50,000 | -201,000 | -145,000 | 119,000 | 87,000 |
| Other Operating Activity | 221,000 | 179,000 | 134,000 | -100,000 | -366,000 |
| Operating Cash Flow | $1,886,000 | $1,334,000 | $1,272,000 | $1,718,000 | $2,233,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -527,000 | -425,000 | -408,000 | -404,000 | -403,000 |
| Net Acquisitions | -101,000 | -2,164,000 | -611,000 | -144,000 | 424,000 |
| Other Investing Activity | -3,000 | 41,000 | -42,000 | 5,000 | 0 |
| Investing Cash Flow | $-631,000 | $-2,548,000 | $-1,061,000 | $-543,000 | $21,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 410,000 | 1,846,000 | 2,592,000 | 0 | 0 |
| Debt Repayment | -1,012,000 | -303,000 | -1,844,000 | -2,000 | -2,000 |
| Common Stock Issued | 79,000 | 73,000 | 72,000 | 123,000 | 129,000 |
| Common Stock Repurchased | -450,000 | -151,000 | -275,000 | -1,408,000 | -2,199,000 |
| Dividend Paid | -353,000 | -331,000 | -314,000 | -378,000 | -309,000 |
| Other Financing Activity | -62,000 | -50,000 | -71,000 | -67,000 | -159,000 |
| Financing Cash Flow | $-1,388,000 | $1,084,000 | $160,000 | $-1,732,000 | $-2,540,000 |
| Exchange Rate Effect | 4,000 | -7,000 | N/A | N/A | N/A |
| Beginning Cash Position | 549,000 | 686,000 | 315,000 | 872,000 | 1,158,000 |
| End Cash Position | 420,000 | 549,000 | 686,000 | 315,000 | 872,000 |
| Net Cash Flow | $-129,000 | $-137,000 | $371,000 | $-557,000 | $-286,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,886,000 | 1,334,000 | 1,272,000 | 1,718,000 | 2,233,000 |
| Capital Expenditure | -527,000 | -425,000 | -408,000 | -404,000 | -403,000 |
| Free Cash Flow | 1,359,000 | 909,000 | 864,000 | 1,314,000 | 1,830,000 |